Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Clonal Hematopoiesis and Its Relationship to Cardiovascular Disease in Hodgkin Lymphoma Survivors

NCT05705531 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT05705531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05705531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Clonal Hematopoiesis and Its Relationship to Cardiovascular Disease in Hodgkin Lymphoma Survivors
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Recruiting
Start date
August 18, 2023
Completion date
October 1, 2028
Enrollment
190 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disorder, classic hodgkin lymphoma, clonal hematopoiesis